{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:01:26Z","timestamp":1787742086323,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.clim.2020.108462","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T23:18:16Z","timestamp":1589152696000},"page":"108462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis"],"prefix":"10.1016","volume":"216","author":[{"given":"Xiaoxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyi","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2020.108462_bb0005","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2020.108462_bb0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2020.108462_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48\u201349","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2020.108462_bb0020","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8206.1","article-title":"Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms","volume":"5","author":"Phillips","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.clim.2020.108462_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.1998.tb01217.x","article-title":"Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis","volume":"164","author":"Vincent","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2020.108462_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2008.04.038","article-title":"How myasthenia gravis alters the safety factor for neuromuscular transmission","volume":"201\u2013202","author":"Ruff","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2020.108462_bb0035","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Tuzun","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2020.108462_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1432-1033.1993.tb18027.x","article-title":"Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits","volume":"215","author":"Beeson","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.clim.2020.108462_bb0045","first-page":"495","article-title":"The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit","volume":"69","author":"Brocke","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2020.108462_bb0050","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1212\/WNL.48.6.1643","article-title":"Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis","volume":"48","author":"Wang","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2020.108462_bb0055","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.50.4.1045","article-title":"T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis","volume":"50","author":"Wang","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2020.108462_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mus.25973","article-title":"B cells in the pathophysiology of myasthenia gravis","volume":"57","author":"Yi","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clim.2020.108462_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1196\/annals.1405.023","article-title":"Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis","volume":"1132","author":"Meriggioli","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2020.108462_bb0070","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.4049\/jimmunol.157.7.3192","article-title":"B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor","volume":"157","author":"Rosenberg","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0075","first-page":"231","article-title":"Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes","volume":"124","author":"Ofosu-Appiah","year":"1994","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.clim.2020.108462_bb0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI113401","article-title":"Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients","volume":"81","author":"Melms","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2020.108462_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-5728(94)90044-2","article-title":"Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells","volume":"50","author":"Yi","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2020.108462_bb0090","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2020.108462_bb0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/nyas.13591","article-title":"An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients","volume":"1413","author":"Villegas","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2020.108462_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2018.11.005","article-title":"Il-23\/Th17 cell pathway: a promising target to alleviate thymic inflammation maintenance in myasthenia gravis","volume":"98","author":"Villegas","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2020.108462_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2012.06791.x","article-title":"Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17","volume":"1274","author":"Gradolatto","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2020.108462_bb0110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clim.2020.108462_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Wang","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0120","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/eji.201445064","article-title":"IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis","volume":"45","author":"Schaffert","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2020.108462_bb0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WCO.0000000000000205","article-title":"Advances in the immunopathogenesis of multiple sclerosis","volume":"28","author":"Yadav","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.clim.2020.108462_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2017.12.006","article-title":"Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis","volume":"87","author":"van Hamburg","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2020.108462_bb0140","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cyto.a.22317","article-title":"Flow-cytometric analysis of rare antigen-specific T cells","volume":"83","author":"Bacher","year":"2013","journal-title":"Cytometry A"},{"key":"10.1016\/j.clim.2020.108462_bb0145","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI14255","article-title":"Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice","volume":"109","author":"Yang","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2020.108462_bb0150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1749-6632.1993.tb22887.x","article-title":"T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis","volume":"681","author":"Moiola","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2020.108462_bb0155","first-page":"1600","article-title":"Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis","author":"Hu","year":"2017","journal-title":"8"},{"key":"10.1016\/j.clim.2020.108462_bb0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.expneurol.2015.02.010","article-title":"Thymoma related myasthenia gravis in humans and potential animal models","volume":"270","author":"Marx","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.clim.2020.108462_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2020.108462_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2013.01.080","article-title":"Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1\/Th17 responses and inducing regulatory T cells","volume":"30","author":"Souza-Moreira","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.clim.2020.108462_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-5728(00)00250-2","article-title":"T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis","volume":"108","author":"Wang","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2020.108462_bb0185","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0190","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2020.108462_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2012.00129","article-title":"TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic?","volume":"3","author":"Marwaha","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0200","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/eji.200737973","article-title":"CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity","volume":"38","author":"Bai","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","article-title":"Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients","volume":"225","author":"Masuda","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2020.108462_bb0210","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-gamma, and GM-CSF and diminished IL-10 production","volume":"196","author":"Cao","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0215","doi-asserted-by":"crossref","first-page":"637649","DOI":"10.1155\/2013\/637649","article-title":"Enumeration and characterization of human memory T cells by enzyme-linked immunospot assays","volume":"2013","author":"Calarota","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0220","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/imm.12106","article-title":"Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay","volume":"139","author":"Calarota","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2020.108462_bb0225","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/08916930903555935","article-title":"Thymoma and paraneoplastic myasthenia gravis","volume":"43","author":"Marx","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2020.108462_bb0230","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.humimm.2013.06.020","article-title":"Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis","volume":"74","author":"Klein","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2020.108462_bb0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2014.04.008","article-title":"Autoimmune regulator expression in thymomas with or without autoimmune disease","volume":"161","author":"Liu","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2020.108462_bb0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2008.06.016","article-title":"Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis","volume":"201\u2013202","author":"Maclennan","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2020.108462_bb0245","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood.V100.1.159","article-title":"Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas","volume":"100","author":"Str\u00f6bel","year":"2002","journal-title":"Blood"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620300383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620300383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:00:45Z","timestamp":1761494445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661620300383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":49,"alternative-id":["S1521661620300383"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108462","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108462"}}